Literature DB >> 27648965

The Risk of Preeclampsia According to High Thyroid Function in Pregnancy Differs by hCG Concentration.

Tim I M Korevaar1, Eric A P Steegers1, Layal Chaker1, Marco Medici1, Vincent W V Jaddoe1, Theo J Visser1, Yolanda B de Rijke1, Robin P Peeters1.   

Abstract

CONTEXT: During pregnancy, there is an increased demand for thyroid hormone. The pregnancy hormone human chorionic gonadotropin (hCG) is an important physiological stimulator of thyroid function. Already high-normal maternal free T4 concentrations are associated with a higher risk of preeclampsia.
OBJECTIVE: The objective of the investigation was to study our hypothesis that hCG concentrations can distinguish a physiological form of high thyroid function from a more pathological form of high thyroid function and that the risk of preeclampsia would differ accordingly.
DESIGN: TSH, free T4, hCG, or thyroperoxidase antibody concentrations were determined in pregnant women participating in a population-based prospective cohort study.
SETTING: The study was conducted in the general community. PARTICIPANTS: A nonselected sample of 5146 pregnant women participated in the study.
INTERVENTIONS: There were no interventions. MAIN OUTCOME MEASURE(S): Preeclampsia was measured.
RESULTS: Women with high hCG-associated high thyroid function did not have a higher risk of preeclampsia than women with normal thyroid function. In contrast, women with low hCG and high thyroid function had a 3.4- to 11.1-fold higher risk of preeclampsia. These risk estimates were amplified in women with a high body mass index. Women with a low hCG and suppressed TSH (<0.10 mU/L) had a 3.2- to 8.9-fold higher risk of preeclampsia. hCG was not associated with preeclampsia, and results remained similar after exclusion of thyroperoxidase antibody-positive women.
CONCLUSION: This study suggests that, in contrast to women with a high hCG associated high thyroid function, women with low hCG and high thyroid function during pregnancy are at a higher risk of developing preeclampsia. The additional measurement of hCG may therefore help to distinguish a more pathological form of high thyroid function and women at a high risk of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27648965     DOI: 10.1210/jc.2016-2397

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Thyroid disease in pregnancy: new insights in diagnosis and clinical management.

Authors:  Tim I M Korevaar; Marco Medici; Theo J Visser; Robin P Peeters
Journal:  Nat Rev Endocrinol       Date:  2017-08-04       Impact factor: 43.330

2.  Maternal use of drugs and preeclampsia.

Authors:  Heidi Sahlman; Marjaana Koponen; Hani El-Nezami; Kirsi Vähäkangas; Leea Keski-Nisula
Journal:  Br J Clin Pharmacol       Date:  2019-12-15       Impact factor: 4.335

3.  Effect of Hyperthyroidism Control During Pregnancy on Maternal and Fetal Outcome: A Systematic Review and Meta-Analysis.

Authors:  Jose Mario Alves Junior; Wanderley Marques Bernardo; Laura Sterian Ward; Danilo Villagelin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-24       Impact factor: 6.055

4.  Identifying Non-Linear Association Between Maternal Free Thyroxine and Risk of Preterm Delivery by a Machine Learning Model.

Authors:  Yulai Zhou; Yindi Liu; Yuan Zhang; Yong Zhang; Weibin Wu; Jianxia Fan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

Review 5.  The application of new concepts of the assessment of the thyroid state to pregnant women.

Authors:  Stephen P Fitzgerald; Nigel G Bean; Samuel P Fitzgerald; Henrik Falhammar
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-16       Impact factor: 6.055

6.  Dendritic polyglycerol nanoparticles show charge dependent bio-distribution in early human placental explants and reduce hCG secretion.

Authors:  Herbert Juch; Liudmila Nikitina; Sabine Reimann; Martin Gauster; Gottfried Dohr; Barbara Obermayer-Pietsch; Denise Hoch; Karin Kornmueller; Rainer Haag
Journal:  Nanotoxicology       Date:  2018-01-15       Impact factor: 5.913

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.